Open tender · Germany · Contract notice
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Perindopril und Amlodipin, ATC C09BB04 für die Zeit 01.04.2025 - 31.03.2027
DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Perindopril und Amlodipin, ATC C09BB04 für die Zeit…”. Bids close on 5 February 2027. To qualify, bidders need at least one similar completed work.
The work
Conclusion of a non-exclusive discount agreement for the active substance Perindopril and Amlodipin, ATC C09BB04, for the period 01.04.2025 - 31.03.2027.
- Agreement must be concluded via the online portal www.dtvp.de/center
- Submission of specific documents (offer letter, contract acknowledgment, annexes 1 & 2) via email
Key facts
- Contract period
- 01.04.2025 - 31.03.2027
- Evaluation
- The process is described as a non-exclusive agreement, not a formal competitive bid.
What it takes to qualify
Worth a closer look
- The tender is for a discount agreement, not a supply contract, which may affect standard tender requirements.
- The document states it is not a formal procurement procedure under cartel law, but uses an 'Open Procedure' form for technical reasons.
Experience
- At least 1 similar work — Experience with pharmaceutical discount agreements is implied but not explicitly stated as a requirement.
Certifications and registrations
GST registration (optional)Not mentioned in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- AngebotsschreibenSubmission via email to openhouse@dak.de.
- Anerkennung der vertraglichen Maßgaben der DAK-GesundheitSubmission via email to openhouse@dak.de.
- Anlage 1 zum VertragSubmission via email to openhouse@dak.de.
- Anlage 2 zum VertragSubmission as an Excel file via email to openhouse@dak.de.